pSivida and Nicox Enter Strategic Collaboration Agreement to Develop Sustained Release Drug to Lower Intraocular Pressure in ...
WATERTOWN, Mass. and SOPHIA ANTIPOLIS, France, Oct. 10, 2017 (GLOBE NEWSWIRE) -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, and Nicox S.A. (Euronext Paris: FR0013018124, COX), the …